FeedingTrends
Molecular Diagnostics Market Size, Share, Analysis Report
7 months ago
3 min read

Molecular Diagnostics Market Size, Share, Analysis Report

The Global Molecular Diagnostics Market is expected to be around US$ 16.90 billion by 2028 and will grow at a CAGR of more than 9% in the given forecast period.

Molecular diagnostic tests are wont to detect specific sequences in DNA or RNA, including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, etc. to further diagnose the disease. These are cumulative techniques for analysing biological markers at the molecular level, like genome and proteome. These techniques are used for diagnosis of the varied infectious diseases, cancer, etc. and is additionally wont to check the genetic predisposition to a disease.

The factors such growth within the prevalence of the infectious diseases and various sorts of cancer, rise in awareness and acceptance of personalized medicines, growth within the biomarker identification, and advancement in molecular diagnostics drive the market growth. Stringent regulatory requirements for the approval of latest molecular diagnostics techniques hampers the expansion of the market. Nevertheless, increase in adoption of the molecular diagnostics within the emerging economies provide growth opportunities for the market.

The global Molecular Diagnostics market is segregated on the basis of Product & Service as Reagents & Kits, Instruments, and Software and Service. Based on Technology the global Molecular Diagnostics market is segmented in Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and NGS, DNA Microarrays, In Situ Hybridization, and Other Technologies.

Based on Application, the global Molecular Diagnostics market is segmented in Infectious Disease, Oncology, Genetic Tests, and Other Applications. The report also bifurcates the global Molecular Diagnostics market based on End User in Hospital and Academic Laboratories, Reference Laboratories, and Other End-Users.

The global Molecular Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Molecular Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Browse Full Report from Here: https://www.marketresearchengine.com/molecular-diagnostics-market-report

Competitive Rivalry

Roche Diagnostics, QIAGEN N.V., Hologic Inc, Abbott Laboratories, Grifols, Siemens Healthcare, Becton, Dickinson, Beckman Coulter Inc., bioMérieux SA, and others are among the major players in the global Molecular Diagnostics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Molecular Diagnostics Market has been segmented as below:

Molecular Diagnostics Market, By Product & Service

  • Reagents & Kits

  • Instruments

  • Software and Service

Molecular Diagnostics Market, By Technology

  • Polymerase Chain Reaction (PCR)

  • Isothermal Nucleic Acid Amplification Technology (INAAT)

  • DNA Sequencing and NGS

  • DNA Microarrays

  • In Situ Hybridization

  • Other Technologies

Molecular Diagnostics Market, By Application

  • Infectious Disease

  • Oncology

  • Genetic Tests

  • Other Applications

Molecular Diagnostics Market, By End User

  • Hospital and Academic Laboratories

  • Reference Laboratories

  • Other End-Users

Molecular Diagnostics Market, By Region

  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World

Molecular Diagnostics Market, By Company

  • Roche Diagnostics

  • QIAGEN N.V.

  • Hologic Inc

  • Abbott Laboratories

  • Grifols

  • Siemens Healthcare

  • Becton

  • Dickinson

  • Beckman Coulter Inc.

  • bioMérieux SA

  • Danaher Corporation

The report covers:

  • Global Molecular Diagnostics market sizes from 2021 to 2028, along with CAGR for 2023-2028

  • Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028

  • Global Molecular Diagnostics market trends, covering comprehensive range of consumer trends & manufacturer trends

  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Molecular Diagnostics market

Request Sample Report from here:

https://www.marketresearchengine.com/molecular-diagnostics-market-report

  • Major market opportunities and challenges in forecast timeframe to be focused

  • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management

  • Comprehensive company profiles of the key industry players

Report Scope:

The global Molecular Diagnostics market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics.

The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Molecular Diagnostics market share. Major industry players with significant revenue share include Roche Diagnostics, QIAGEN N.V., Hologic Inc, Abbott Laboratories, Grifols, Siemens Healthcare, Becton, Dickinson, Beckman Coulter Inc., bioMérieux SA, and others.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com

Appreciate the creator